Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment.
Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, Wang X, He C, Pan H. · 2013
Read Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. by Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, Wang X, He C, Pan H. (2013) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc3824660.txt.
Description
X. Sui and a large team of co-authors review autophagy and drug resistance in Cell Death and Disease in 2013. Autophagy is the cell's recycling system, breaking down worn parts and excess proteins. Cancer drugs often switch it on, and the review asks whether that helps or hurts treatment.
Recycling can keep cancer cells alive under drug stress, feeding resistance. In other settings it can push cells toward death and boost drug effect. Which way it cuts depends on the tumor and the drug. The review weighs proof for blocking or boosting the process to beat resistance. Their verdict is that autophagy is a strong drug target, but only with care for each case, since blind use could backfire.
Catalog record
| CREATOR | Sui X, Chen R, Wang Z, Huang Z, Kong N, Zhang M, Han W, Lou F, Yang J, Zhang Q, Wang X, He C, Pan H. |
|---|---|
| YEAR | 2013 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 58 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |